111 related articles for article (PubMed ID: 24623860)
21. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.
Lee KD; Chen SC; Chan CH; Lu CH; Chen CC; Lin JT; Chen MF; Huang SH; Yeh CM; Chen MC
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2647-55. PubMed ID: 18843006
[TBL] [Abstract][Full Text] [Related]
22. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
23. Thyroid cancers in Ibadan, Nigeria.
Thomas JO; Ogunbiyi JO
East Afr Med J; 1995 Apr; 72(4):231-3. PubMed ID: 7621758
[TBL] [Abstract][Full Text] [Related]
24. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
McCredie M; Macfarlane GJ; Bell J; Coates M
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
[TBL] [Abstract][Full Text] [Related]
25. Incidence of second primary malignancies in patients with esophageal cancer: a comprehensive review.
Nandy N; Dasanu CA
Curr Med Res Opin; 2013 Sep; 29(9):1055-65. PubMed ID: 23777310
[TBL] [Abstract][Full Text] [Related]
26. Association of thyroid, breast and renal cell cancer: a population-based study of the prevalence of second malignancies.
Van Fossen VL; Wilhelm SM; Eaton JL; McHenry CR
Ann Surg Oncol; 2013 Apr; 20(4):1341-7. PubMed ID: 23263698
[TBL] [Abstract][Full Text] [Related]
27. Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis.
Subramanian S; Goldstein DP; Parlea L; Thabane L; Ezzat S; Ibrahim-Zada I; Straus S; Brierley JD; Tsang RW; Gafni A; Rotstein L; Sawka AM
Thyroid; 2007 Dec; 17(12):1277-88. PubMed ID: 18020916
[TBL] [Abstract][Full Text] [Related]
28. Nonbreast second malignancies after treatment of primary breast cancer.
Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?
van den Broek EC; Liu L; Posthuma EF; Janssen-Heijnen ML; Coebergh JW; Soerjomataram I
Ann Hematol; 2014 Jan; 93(1):157-62. PubMed ID: 24381068
[TBL] [Abstract][Full Text] [Related]
30. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
Jung GW; Dover DC; Salopek TG
Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
[TBL] [Abstract][Full Text] [Related]
31. Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.
Teng CJ; Huon LK; Hu YW; Yeh CM; Chao Y; Yang MH; Chen TJ; Hung YP; Liu CJ
Medicine (Baltimore); 2015 Oct; 94(43):e1803. PubMed ID: 26512575
[TBL] [Abstract][Full Text] [Related]
32. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
33. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
34. Secondary malignancy among seminoma patients treated with adjuvant radiation therapy.
Chao CK; Lai PP; Michalski JM; Perez CA
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):831-5. PubMed ID: 7591890
[TBL] [Abstract][Full Text] [Related]
35. Multiple primary cancers in patients with gastric cancer.
Wu CW; Lo SS; Chen JH; Hsieh MC; Li AF; Lui WY
Hepatogastroenterology; 2006; 53(69):463-7. PubMed ID: 16795993
[TBL] [Abstract][Full Text] [Related]
36. Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature.
Vadgaonkar RA; Nayak SS; Doni S; Digumarti L; Mullapally SK; Digumarti R
Indian J Pathol Microbiol; 2021; 64(4):725-731. PubMed ID: 34673592
[TBL] [Abstract][Full Text] [Related]
37. [Second primary cancers after small-cell lung cancer].
Soria JC; Bréchot JM; Lebeau B; Rochemaure J
Bull Cancer; 1997 Aug; 84(8):800-6. PubMed ID: 9339185
[TBL] [Abstract][Full Text] [Related]
38. [Multiple primary malignancies in patients with head and neck cancer].
Miyahara H; Sato T; Yoshino K; Umatani K; Tsuruta Y
Gan No Rinsho; 1990 Dec; 36(15):2529-33. PubMed ID: 2266584
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact?
Prommegger R; Ensinger C; Steiner P; Sauper T; Profanter C; Margreiter R
Anticancer Res; 2004; 24(2C):1049-51. PubMed ID: 15154621
[TBL] [Abstract][Full Text] [Related]
40. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]